Search

Author/Creator Triebwasser, Michael P.

1. Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective. Issue 7 (22nd March 2021)

Authors:
Triebwasser, Michael P.; Barrett, David M.; Bassiri, Hamid; Bunin, Nancy; Elgarten, Caitlin; Freedman, Jason; Geera, Abdallah S.; Monos, Dimitri; Lambert, Michele P.; Olson, Timothy; Seif, Alix E.; Paessler, Michele; Petrosa, Whitney; Reilly, Anne F.; Romberg, Neil; Sullivan, Kathleen E.; Quinn, ...
Journal:
Pediatric blood & cancer
Issue:
Volume 68:Issue 7(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗